TAIWAN · TWSE / TPEx
OP
友霖 · 4166 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$24.151 month +1.5% · 1 year -8.2%
Directors and supervisors hold144,509,17459.5% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold132,928,18854.7% of shares issued
Revenue, 2026-09+41.2%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 友華生技醫藥股份有限公司 | Chairman · Director · Major shareholder (10%+) | 132,928,188 | 132,928,188 | 54.70% | — | 11,339,128 |
| 蔡正弘 | Chairman (corporate representative) | — | 132,636 | 0.05% | — | 152,729 |
| 黃文鴻 | Director (corporate representative) | — | 0 | — | — | — |
| 李宇玲 | Director (corporate representative) | — | 266,551 | 0.11% | — | — |
| 三德觀光大飯店股份有限公司 | Director | 10,290,324 | 10,290,324 | 4.23% | — | — |
| 高偉超 | Director (corporate representative) | — | 0 | — | — | — |
| 蔡孟霖 | Director | 841,217 | 841,217 | 0.35% | — | 1,061,500 |
| 中倫開發股份有限公司 | Director | 449,445 | 449,445 | 0.18% | — | — |
| 宋權峰 | Director (corporate representative) | — | 0 | — | — | — |
| 陳泰明 | Independent director | — | 0 | — | — | — |
| 康照洲 | Independent director | — | 0 | — | — | — |
| 張嘉紋 | Independent director | — | 0 | — | — | — |
| 黃春桐 | President | — | 249,000 | 0.10% | — | — |
| 李元志 | Assistant vice president | — | 261,000 | 0.11% | — | 90,500 |
| 楊品誠 | Assistant vice president | — | 116,739 | 0.05% | — | — |
| 張奕欣 | Chief financial officer · Chief accountant | — | 104,000 | 0.04% | — | — |